Differential regulation of inhibin B rand inhibin A by follicle-stimulating hormone and local growth factors in human granulosa cells from small antral follicles
Ck. Welt et Al. Schneyer, Differential regulation of inhibin B rand inhibin A by follicle-stimulating hormone and local growth factors in human granulosa cells from small antral follicles, J CLIN END, 86(1), 2001, pp. 330-336
Serum inhibin B rises across the luteal-follicular transition, whereas inhi
bin A does not increase until the late follicular phase of the menstrual cy
cle. To test the hypothesis that inhibin B is secreted from preantral and s
mall antral follicles and that FSH and local growth factors differentially
regulate inhibin B and inhibin A from these developing follicles, human ova
ries were obtained after oophorectomy. Basal secretion of inhibin B and inh
ibin A was examined in intact preantral follicles in culture (n = 6). Basal
secretion and regulation of inhibin B and inhibin A secretion by gonadotro
pins, androstenedione, activin A, insulin, and IGF-I were examined in cultu
red granulosa cells from small antral follicles (n = 21). Inhibin B secreti
on from preantral follicle cultures was detectable at baseline (range, 17-9
6 pg/mL), whereas inhibin A was not detectable. In contrast, both inhibin B
and inhibin A were detectable in granulosa cell cultures from small antral
follicles. In granulosa cells from small antral follicles, FSH (30 ng/mL)
stimulated inhibin A 3-fold (10.5 +/- 2.2 to 32.5 +/- 8.3 IU/mL; P < 0.001)
, but not inhibin B secretion (1730 +/- 354 to 2314 +/- 532 pg/mL; P = NS).
Likewise, cAMP (1 mmol/L) stimulated inhibin A 4-fold (16.6 +/- 4.3 to 62.
5 +/- 21.9 IU/mL; P < 0.002), but not inhibin B secretion (2327 +/- 546 to
1877 +/- 377 pg/mL; P = NS). hCG (30 ng/mL) did not stimulate inhibin A or
inhibin B. Androstenedione (10-7 mol/L), activin (30 ng/mL), insulin (30 ng
/mL), and insulin-like growth factor I (IGF-I; 100 ng/mL) alone did not sti
mulate inhibin A or inhibin B secretion. Further, FSH-stimulated inhibin A
secretion was not augmented by androstenedione, activin, insulin, or IGF-I.
In contrast, the combination of IGF-I and FSH was the only treatment that
stimulated inhibin B secretion (1742 +/- 380 to 2881 +/- 731 pg/mL; P < 0.0
3). However, FSH in combination with IGF-T resulted in greater stimulation
of inhibin A (340%) than inhibin B (65%).
These findings demonstrate that inhibin B is secreted from developing prean
tral and small antral follicles, but is not directly stimulated by FSH. How
ever, the combination of FSH and IGF-I enhanced inhibin B secretion. In con
trast, inhibin A is not secreted from preantral follicles, but in small ant
ral follicles FSH and cAMP stimulate inhibin A secretion. Further, FSH in c
ombination with IGF-I results in a greater degree of stimulation of inhibin
A than of inhibin B. These findings suggest that FSH and IGF-I differentia
lly regulate inhibin A and inhibin B secretion. However, additional growth
factors or increasing granulosa cell number may contribute to the preferent
ial serum inhibin B increase across the luteal-follicular transition in the
menstrual cycle.